Crossmark

Consolidative allogeneic hematopoietic stem cell transplantation after chimeric antigen receptor T-cell therapy for relapsed/refractory B-cell acute lymphoblastic leukemia: who? When? Why?

Crossref DOI link: https://doi.org/10.1186/s40364-020-00247-8

Published Online: 2020-11-25

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Jiang, Huiwen

Hu, Yu

Mei, Heng http://orcid.org/0000-0001-7941-2443
Funding

Funding for this research was provided by:

National Key R&D Program of China (2019YFC1316203)
License Information

Text and Data Mining valid from 2020-11-25

Version of Record valid from 2020-11-25
More Information

Article History

Received: 18 September 2020

Accepted: 5 November 2020

First Online: 25 November 2020

Ethics approval and consent to participate

: Not applicable.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below